Navigation Links


Alkahest Appoints Sam Jackson, M.D., MBA as Chief Medical Officer

1/23/2017
SAN CARLOS, Calif. , Jan. 23, 2017  Alkahest Inc. ("Alkahest"), a biotechnology company focused on developing innovative treatments for neurodegenerative diseases and other age-related conditions, announced today that Sam Jackson, MD, MBA, has joined the company as Chief Medical Officer. In this role, Dr. Jackson will lead the translational and clinical development ac... [Comments]

AxioMed Continues International Growth with Workshop and Presentation at Caribbean Neurosciences Symposium in Montego Bay

1/23/2017
Malden, MA (PRWEB) January 23, 2017 AxioMed will be presenting its viscoelastic cervical and lumbar disc replacement at the Caribbean Neurosciences Symposium (CANS) annual meeting in Montego Bay, Jamaica from January 26-28th. “We’re excited to be presenting the benefits of AxioMed’s viscoelas... [Comments]

CallTower Honored with 2017 INTERNET TELEPHONY Product of the Year Award

1/23/2017
South Jordan, Utah (PRWEB) January 23, 2017 CallTower is proud to announce that their hosted Skype for Business solution has been named an INTERNET TELEPHONY Product of the Year Award winner for 2017. For three consecutive years, CallTower has been recognized by INTERNET TELEPHONY as an... [Comments]

G&L Scientific Inc. announces Opening of New Offices in Cambridge, Massachusetts

1/21/2017
Cambridge, MA (PRWEB) January 20, 2017 G&L Scientific Inc, a leading provider of clinical and scientific consulting and resource to the healthcare industry ( http://www.gandlscientific.com ), has announced the opening of new offices in Cambridge, Massachusetts, strengthening and improving... [Comments]

Nipro Corporation and Transonic Systems announce the formation of a Joint Venture

1/21/2017
Ithaca, NY (PRWEB) January 20, 2017 Nipro Corporation (Osaka, Japan) and Transonic Systems Inc. (New York, USA) announced the formation of a Joint Venture (JV) under which Nipro will receive exclusive marketing and sales rights for all non-OEM Transonic products in Japan. As partners for more... [Comments]

Nova Oculus Recruits Emergo to Assist with Global Compliance

1/21/2017
Indian Wells, CA (PRWEB) January 21, 2017 Nova Oculus Partners has forged another key alliance in our ongoing endeavors to bring to market a pioneering medical device for the treatment of Age-Related Macular Degeneration. The company’s chief operating officer, Walter O’Rourke, has signed a... [Comments]

Interpace Diagnostics Announces $4.0 Million Registered Direct Offering of Common Stock

1/21/2017
PARSIPPANY, N.J. , Jan. 20, 2017 Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)("Interpace" or the "Company"), a company that provides clinically useful molecular diagnostic tests and pathology services, today announced that it has entered into a securities purchase agreement with three  institutional investors to purchase an aggregate of 855,000 shares of common stock... [Comments]

Bioptix Announces Streamlining of Workforce

1/21/2017
BOULDER, Colo. , Jan. 20, 2017 Bioptix, Inc. (Nasdaq: BIOP ) ("Bioptix" or the "Company"), announced that on January 14, 2017 the Board of Directors of the Company adopted a plan under which the Company will terminate certain employees associated with the September 2016 acquisition of its subsidiary, Bioptix Diagnostics, Inc.  The Company commenced terminations on Jan... [Comments]

Aratana Therapeutics Named Animal Pharm's Best Company in North America 2016

1/21/2017
LEAWOOD, Kan. , Jan. 20, 2017 Aratana Therapeutics, Inc. (NASDAQ: PETX ), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals, won Animal Pharm's Best Company in North America 2016. Aratana was granted the award based on the FDA approval of three innovative therapeuti... [Comments]

Boston Biomedical Presents Clinical Data on First-in-Class Cancer Stemness Inhibitor Napabucasin at 2017 ASCO GI Symposium

1/21/2017
CAMBRIDGE, Mass. , Jan. 21, 2017   Boston Biomedical , an industry leader in the development of novel compounds designed to target cancer stemness pathways, today presented data from two clinical studies for its lead investigational compound, napabucasin, at the 2017 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in San Francisco . In... [Comments]

[previous] [next]
(Date:12/16/2016)... -- The global wearable medical device market, in terms of value, ... 5.31 billion in 2016, at a CAGR of 18.0% during the ... ... medical devices, launch of a growing number of smartphone-based healthcare apps ... providers, and increasing focus on physical fitness. Furthermore, ...
(Date:12/15/2016)... ... has announced the addition of the "Global Military Biometrics Market 2016-2020" ... global military biometrics market to grow at a CAGR of 7.5% during ... on an in-depth market analysis with inputs from industry experts. The report ... The report also includes a discussion of the key vendors operating in ...
(Date:12/15/2016)... 14, 2016 "Increase in mobile transactions is ... mobile biometrics market is expected to grow from USD ... 2022, at a CAGR of 29.3% between 2016 and ... the growing demand for smart devices, government initiatives, and ... "Software component is expected to grow at a high ...
Breaking Biology News(10 mins):
(Date:1/24/2017)... ... January 24, 2017 , ... Men who have a ... had a positive association with increased prostate growth or benign prostatic hyperplasia, according ... Journal involved 571 Korean men who underwent urological examinations, including serum prostate ...
(Date:1/24/2017)... USA & Geneva, Switerland (PRWEB) , ... January ... ... to announce the first commercially available malaria Plasmodium falciparum culture panels with standard ... falciparum culture panels, which are available in a range of concentrations from six ...
(Date:1/24/2017)... LAVAL, QC , Jan. 24, 2017 /PRNewswire/ - ProMetic ... the "Corporation") announced today that its orally active lead ... Medicine ("PIM") designation by the UK Medicines and Healthcare ... Syndrome ("AS"). A PIM designation is ... promising candidate for the Early Access to Medicines Scheme ...
(Date:1/24/2017)... DC (PRWEB) , ... January 23, 2017 , ... ... and food security, is the first-ever recipient of the National Academy of Sciences ... to global food security and nutrition. , The annual National Academy of Sciences ...
Breaking Biology Technology: